[{"Assets_0_Q2_USD":86332000.0,"CommonStockSharesOutstanding_0_Q2_shares":42994481.0,"EarningsPerShareBasic_1_Q2_USD":0.03,"EarningsPerShareBasic_2_Q2_USD":-0.63,"EarningsPerShareDiluted_1_Q2_USD":0.03,"EarningsPerShareDiluted_2_Q2_USD":-0.63,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-8042000.0,"NetIncomeLoss_1_Q2_USD":5398000.0,"NetIncomeLoss_2_Q2_USD":-14430000.0,"StockholdersEquity_0_Q2_USD":44614000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":31901000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":29895000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":31725000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29895000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170804"}]